Global Intravenous Immune Globulin Therapies Market Growth (Status and Outlook) 2025-2031

September 2025 | 82 pages | ID: GED77A73B74EN
LP Information

Abstracts

According to this study, the global Intravenous Immune Globulin Therapies market size will reach US$ million by 2031.

Immune globulin derived from the plasma of paid and volunteer donors is used in the treatment of an array of disorders, including primary and secondary immune deficiency states and a variety of autoimmune and inflammatory disorders.

United States market for Intravenous Immune Globulin Therapies is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Intravenous Immune Globulin Therapies is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Intravenous Immune Globulin Therapies is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Intravenous Immune Globulin Therapies players cover Baxter, Grifols, CSL Plasma, Octapharma, Biotest, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Intravenous Immune Globulin Therapies Industry Forecast” looks at past sales and reviews total world Intravenous Immune Globulin Therapies sales in 2024, providing a comprehensive analysis by region and market sector of projected Intravenous Immune Globulin Therapies sales for 2025 through 2031. With Intravenous Immune Globulin Therapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravenous Immune Globulin Therapies industry.

This Insight Report provides a comprehensive analysis of the global Intravenous Immune Globulin Therapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Intravenous Immune Globulin Therapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Intravenous Immune Globulin Therapies market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravenous Immune Globulin Therapies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravenous Immune Globulin Therapies.

This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Immune Globulin Therapies market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Liquid Form
• Lyophilized Powder Form

Segmentation by Application:

• Immunodeficiency
• Autoimmune Disease
• Acute Infection

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Baxter
• Grifols
• CSL Plasma
• Octapharma
• Biotest
• Kedrion
• Kamada
• China Biologic Products Holdings
• Hualan Biological Engineering
• Sichuan Yuanda Shuyang Pharmaceutical

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Intravenous Immune Globulin Therapies Market Size (2020-2031)
  2.1.2 Intravenous Immune Globulin Therapies Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Intravenous Immune Globulin Therapies by Country/Region (2020, 2024 & 2031)
2.2 Intravenous Immune Globulin Therapies Segment by Type
  2.2.1 Liquid Form
  2.2.2 Lyophilized Powder Form
2.3 Intravenous Immune Globulin Therapies Market Size by Type
  2.3.1 Intravenous Immune Globulin Therapies Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Intravenous Immune Globulin Therapies Market Size Market Share by Type (2020-2025)
2.4 Intravenous Immune Globulin Therapies Segment by Application
  2.4.1 Immunodeficiency
  2.4.2 Autoimmune Disease
  2.4.3 Acute Infection
2.5 Intravenous Immune Globulin Therapies Market Size by Application
  2.5.1 Intravenous Immune Globulin Therapies Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Intravenous Immune Globulin Therapies Market Size Market Share by Application (2020-2025)

3 INTRAVENOUS IMMUNE GLOBULIN THERAPIES MARKET SIZE BY PLAYER

3.1 Intravenous Immune Globulin Therapies Market Size Market Share by Player
  3.1.1 Global Intravenous Immune Globulin Therapies Revenue by Player (2020-2025)
  3.1.2 Global Intravenous Immune Globulin Therapies Revenue Market Share by Player (2020-2025)
3.2 Global Intravenous Immune Globulin Therapies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 INTRAVENOUS IMMUNE GLOBULIN THERAPIES BY REGION

4.1 Intravenous Immune Globulin Therapies Market Size by Region (2020-2025)
4.2 Global Intravenous Immune Globulin Therapies Annual Revenue by Country/Region (2020-2025)
4.3 Americas Intravenous Immune Globulin Therapies Market Size Growth (2020-2025)
4.4 APAC Intravenous Immune Globulin Therapies Market Size Growth (2020-2025)
4.5 Europe Intravenous Immune Globulin Therapies Market Size Growth (2020-2025)
4.6 Middle East & Africa Intravenous Immune Globulin Therapies Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Intravenous Immune Globulin Therapies Market Size by Country (2020-2025)
5.2 Americas Intravenous Immune Globulin Therapies Market Size by Type (2020-2025)
5.3 Americas Intravenous Immune Globulin Therapies Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Intravenous Immune Globulin Therapies Market Size by Region (2020-2025)
6.2 APAC Intravenous Immune Globulin Therapies Market Size by Type (2020-2025)
6.3 APAC Intravenous Immune Globulin Therapies Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Intravenous Immune Globulin Therapies Market Size by Country (2020-2025)
7.2 Europe Intravenous Immune Globulin Therapies Market Size by Type (2020-2025)
7.3 Europe Intravenous Immune Globulin Therapies Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Intravenous Immune Globulin Therapies by Region (2020-2025)
8.2 Middle East & Africa Intravenous Immune Globulin Therapies Market Size by Type (2020-2025)
8.3 Middle East & Africa Intravenous Immune Globulin Therapies Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL INTRAVENOUS IMMUNE GLOBULIN THERAPIES MARKET FORECAST

10.1 Global Intravenous Immune Globulin Therapies Forecast by Region (2026-2031)
  10.1.1 Global Intravenous Immune Globulin Therapies Forecast by Region (2026-2031)
  10.1.2 Americas Intravenous Immune Globulin Therapies Forecast
  10.1.3 APAC Intravenous Immune Globulin Therapies Forecast
  10.1.4 Europe Intravenous Immune Globulin Therapies Forecast
  10.1.5 Middle East & Africa Intravenous Immune Globulin Therapies Forecast
10.2 Americas Intravenous Immune Globulin Therapies Forecast by Country (2026-2031)
  10.2.1 United States Market Intravenous Immune Globulin Therapies Forecast
  10.2.2 Canada Market Intravenous Immune Globulin Therapies Forecast
  10.2.3 Mexico Market Intravenous Immune Globulin Therapies Forecast
  10.2.4 Brazil Market Intravenous Immune Globulin Therapies Forecast
10.3 APAC Intravenous Immune Globulin Therapies Forecast by Region (2026-2031)
  10.3.1 China Intravenous Immune Globulin Therapies Market Forecast
  10.3.2 Japan Market Intravenous Immune Globulin Therapies Forecast
  10.3.3 Korea Market Intravenous Immune Globulin Therapies Forecast
  10.3.4 Southeast Asia Market Intravenous Immune Globulin Therapies Forecast
  10.3.5 India Market Intravenous Immune Globulin Therapies Forecast
  10.3.6 Australia Market Intravenous Immune Globulin Therapies Forecast
10.4 Europe Intravenous Immune Globulin Therapies Forecast by Country (2026-2031)
  10.4.1 Germany Market Intravenous Immune Globulin Therapies Forecast
  10.4.2 France Market Intravenous Immune Globulin Therapies Forecast
  10.4.3 UK Market Intravenous Immune Globulin Therapies Forecast
  10.4.4 Italy Market Intravenous Immune Globulin Therapies Forecast
  10.4.5 Russia Market Intravenous Immune Globulin Therapies Forecast
10.5 Middle East & Africa Intravenous Immune Globulin Therapies Forecast by Region (2026-2031)
  10.5.1 Egypt Market Intravenous Immune Globulin Therapies Forecast
  10.5.2 South Africa Market Intravenous Immune Globulin Therapies Forecast
  10.5.3 Israel Market Intravenous Immune Globulin Therapies Forecast
  10.5.4 Turkey Market Intravenous Immune Globulin Therapies Forecast
10.6 Global Intravenous Immune Globulin Therapies Forecast by Type (2026-2031)
10.7 Global Intravenous Immune Globulin Therapies Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Intravenous Immune Globulin Therapies Forecast

11 KEY PLAYERS ANALYSIS

11.1 Baxter
  11.1.1 Baxter Company Information
  11.1.2 Baxter Intravenous Immune Globulin Therapies Product Offered
  11.1.3 Baxter Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Baxter Main Business Overview
  11.1.5 Baxter Latest Developments
11.2 Grifols
  11.2.1 Grifols Company Information
  11.2.2 Grifols Intravenous Immune Globulin Therapies Product Offered
  11.2.3 Grifols Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Grifols Main Business Overview
  11.2.5 Grifols Latest Developments
11.3 CSL Plasma
  11.3.1 CSL Plasma Company Information
  11.3.2 CSL Plasma Intravenous Immune Globulin Therapies Product Offered
  11.3.3 CSL Plasma Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 CSL Plasma Main Business Overview
  11.3.5 CSL Plasma Latest Developments
11.4 Octapharma
  11.4.1 Octapharma Company Information
  11.4.2 Octapharma Intravenous Immune Globulin Therapies Product Offered
  11.4.3 Octapharma Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Octapharma Main Business Overview
  11.4.5 Octapharma Latest Developments
11.5 Biotest
  11.5.1 Biotest Company Information
  11.5.2 Biotest Intravenous Immune Globulin Therapies Product Offered
  11.5.3 Biotest Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Biotest Main Business Overview
  11.5.5 Biotest Latest Developments
11.6 Kedrion
  11.6.1 Kedrion Company Information
  11.6.2 Kedrion Intravenous Immune Globulin Therapies Product Offered
  11.6.3 Kedrion Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Kedrion Main Business Overview
  11.6.5 Kedrion Latest Developments
11.7 Kamada
  11.7.1 Kamada Company Information
  11.7.2 Kamada Intravenous Immune Globulin Therapies Product Offered
  11.7.3 Kamada Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Kamada Main Business Overview
  11.7.5 Kamada Latest Developments
11.8 China Biologic Products Holdings
  11.8.1 China Biologic Products Holdings Company Information
  11.8.2 China Biologic Products Holdings Intravenous Immune Globulin Therapies Product Offered
  11.8.3 China Biologic Products Holdings Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 China Biologic Products Holdings Main Business Overview
  11.8.5 China Biologic Products Holdings Latest Developments
11.9 Hualan Biological Engineering
  11.9.1 Hualan Biological Engineering Company Information
  11.9.2 Hualan Biological Engineering Intravenous Immune Globulin Therapies Product Offered
  11.9.3 Hualan Biological Engineering Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Hualan Biological Engineering Main Business Overview
  11.9.5 Hualan Biological Engineering Latest Developments
11.10 Sichuan Yuanda Shuyang Pharmaceutical
  11.10.1 Sichuan Yuanda Shuyang Pharmaceutical Company Information
  11.10.2 Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Product Offered
  11.10.3 Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Sichuan Yuanda Shuyang Pharmaceutical Main Business Overview
  11.10.5 Sichuan Yuanda Shuyang Pharmaceutical Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Intravenous Immune Globulin Therapies Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Intravenous Immune Globulin Therapies Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Liquid Form
Table 4. Major Players of Lyophilized Powder Form
Table 5. Intravenous Immune Globulin Therapies Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Intravenous Immune Globulin Therapies Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Intravenous Immune Globulin Therapies Market Size Market Share by Type (2020-2025)
Table 8. Intravenous Immune Globulin Therapies Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Intravenous Immune Globulin Therapies Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Intravenous Immune Globulin Therapies Market Size Market Share by Application (2020-2025)
Table 11. Global Intravenous Immune Globulin Therapies Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Intravenous Immune Globulin Therapies Revenue Market Share by Player (2020-2025)
Table 13. Intravenous Immune Globulin Therapies Key Players Head office and Products Offered
Table 14. Intravenous Immune Globulin Therapies Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Intravenous Immune Globulin Therapies Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Intravenous Immune Globulin Therapies Market Size Market Share by Region (2020-2025)
Table 19. Global Intravenous Immune Globulin Therapies Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Intravenous Immune Globulin Therapies Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Intravenous Immune Globulin Therapies Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Intravenous Immune Globulin Therapies Market Size Market Share by Country (2020-2025)
Table 23. Americas Intravenous Immune Globulin Therapies Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Intravenous Immune Globulin Therapies Market Size Market Share by Type (2020-2025)
Table 25. Americas Intravenous Immune Globulin Therapies Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Intravenous Immune Globulin Therapies Market Size Market Share by Application (2020-2025)
Table 27. APAC Intravenous Immune Globulin Therapies Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Intravenous Immune Globulin Therapies Market Size Market Share by Region (2020-2025)
Table 29. APAC Intravenous Immune Globulin Therapies Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Intravenous Immune Globulin Therapies Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Intravenous Immune Globulin Therapies Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Intravenous Immune Globulin Therapies Market Size Market Share by Country (2020-2025)
Table 33. Europe Intravenous Immune Globulin Therapies Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Intravenous Immune Globulin Therapies Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Intravenous Immune Globulin Therapies Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Intravenous Immune Globulin Therapies Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Intravenous Immune Globulin Therapies Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Intravenous Immune Globulin Therapies
Table 39. Key Market Challenges & Risks of Intravenous Immune Globulin Therapies
Table 40. Key Industry Trends of Intravenous Immune Globulin Therapies
Table 41. Global Intravenous Immune Globulin Therapies Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Intravenous Immune Globulin Therapies Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Intravenous Immune Globulin Therapies Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Intravenous Immune Globulin Therapies Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Baxter Details, Company Type, Intravenous Immune Globulin Therapies Area Served and Its Competitors
Table 46. Baxter Intravenous Immune Globulin Therapies Product Offered
Table 47. Baxter Intravenous Immune Globulin Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Baxter Main Business
Table 49. Baxter Latest Developments
Table 50. Grifols Details, Company Type, Intravenous Immune Globulin Therapies Area Served and Its Competitors
Table 51. Grifols Intravenous Immune Globulin Therapies Product Offered
Table 52. Grifols Intravenous Immune Globulin Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Grifols Main Business
Table 54. Grifols Latest Developments
Table 55. CSL Plasma Details, Company Type, Intravenous Immune Globulin Therapies Area Served and Its Competitors
Table 56. CSL Plasma Intravenous Immune Globulin Therapies Product Offered
Table 57. CSL Plasma Intravenous Immune Globulin Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. CSL Plasma Main Business
Table 59. CSL Plasma Latest Developments
Table 60. Octapharma Details, Company Type, Intravenous Immune Globulin Therapies Area Served and Its Competitors
Table 61. Octapharma Intravenous Immune Globulin Therapies Product Offered
Table 62. Octapharma Intravenous Immune Globulin Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Octapharma Main Business
Table 64. Octapharma Latest Developments
Table 65. Biotest Details, Company Type, Intravenous Immune Globulin Therapies Area Served and Its Competitors
Table 66. Biotest Intravenous Immune Globulin Therapies Product Offered
Table 67. Biotest Intravenous Immune Globulin Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Biotest Main Business
Table 69. Biotest Latest Developments
Table 70. Kedrion Details, Company Type, Intravenous Immune Globulin Therapies Area Served and Its Competitors
Table 71. Kedrion Intravenous Immune Globulin Therapies Product Offered
Table 72. Kedrion Intravenous Immune Globulin Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Kedrion Main Business
Table 74. Kedrion Latest Developments
Table 75. Kamada Details, Company Type, Intravenous Immune Globulin Therapies Area Served and Its Competitors
Table 76. Kamada Intravenous Immune Globulin Therapies Product Offered
Table 77. Kamada Intravenous Immune Globulin Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Kamada Main Business
Table 79. Kamada Latest Developments
Table 80. China Biologic Products Holdings Details, Company Type, Intravenous Immune Globulin Therapies Area Served and Its Competitors
Table 81. China Biologic Products Holdings Intravenous Immune Globulin Therapies Product Offered
Table 82. China Biologic Products Holdings Intravenous Immune Globulin Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. China Biologic Products Holdings Main Business
Table 84. China Biologic Products Holdings Latest Developments
Table 85. Hualan Biological Engineering Details, Company Type, Intravenous Immune Globulin Therapies Area Served and Its Competitors
Table 86. Hualan Biological Engineering Intravenous Immune Globulin Therapies Product Offered
Table 87. Hualan Biological Engineering Intravenous Immune Globulin Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Hualan Biological Engineering Main Business
Table 89. Hualan Biological Engineering Latest Developments
Table 90. Sichuan Yuanda Shuyang Pharmaceutical Details, Company Type, Intravenous Immune Globulin Therapies Area Served and Its Competitors
Table 91. Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Product Offered
Table 92. Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Sichuan Yuanda Shuyang Pharmaceutical Main Business
Table 94. Sichuan Yuanda Shuyang Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Intravenous Immune Globulin Therapies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Intravenous Immune Globulin Therapies Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Intravenous Immune Globulin Therapies Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Intravenous Immune Globulin Therapies Sales Market Share by Country/Region (2024)
Figure 8. Intravenous Immune Globulin Therapies Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Intravenous Immune Globulin Therapies Market Size Market Share by Type in 2024
Figure 10. Intravenous Immune Globulin Therapies in Immunodeficiency
Figure 11. Global Intravenous Immune Globulin Therapies Market: Immunodeficiency (2020-2025) & ($ millions)
Figure 12. Intravenous Immune Globulin Therapies in Autoimmune Disease
Figure 13. Global Intravenous Immune Globulin Therapies Market: Autoimmune Disease (2020-2025) & ($ millions)
Figure 14. Intravenous Immune Globulin Therapies in Acute Infection
Figure 15. Global Intravenous Immune Globulin Therapies Market: Acute Infection (2020-2025) & ($ millions)
Figure 16. Global Intravenous Immune Globulin Therapies Market Size Market Share by Application in 2024
Figure 17. Global Intravenous Immune Globulin Therapies Revenue Market Share by Player in 2024
Figure 18. Global Intravenous Immune Globulin Therapies Market Size Market Share by Region (2020-2025)
Figure 19. Americas Intravenous Immune Globulin Therapies Market Size 2020-2025 ($ millions)
Figure 20. APAC Intravenous Immune Globulin Therapies Market Size 2020-2025 ($ millions)
Figure 21. Europe Intravenous Immune Globulin Therapies Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Intravenous Immune Globulin Therapies Market Size 2020-2025 ($ millions)
Figure 23. Americas Intravenous Immune Globulin Therapies Value Market Share by Country in 2024
Figure 24. United States Intravenous Immune Globulin Therapies Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Intravenous Immune Globulin Therapies Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Intravenous Immune Globulin Therapies Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Intravenous Immune Globulin Therapies Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Intravenous Immune Globulin Therapies Market Size Market Share by Region in 2024
Figure 29. APAC Intravenous Immune Globulin Therapies Market Size Market Share by Type (2020-2025)
Figure 30. APAC Intravenous Immune Globulin Therapies Market Size Market Share by Application (2020-2025)
Figure 31. China Intravenous Immune Globulin Therapies Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Intravenous Immune Globulin Therapies Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Intravenous Immune Globulin Therapies Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Intravenous Immune Globulin Therapies Market Size Growth 2020-2025 ($ millions)
Figure 35. India Intravenous Immune Globulin Therapies Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Intravenous Immune Globulin Therapies Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Intravenous Immune Globulin Therapies Market Size Market Share by Country in 2024
Figure 38. Europe Intravenous Immune Globulin Therapies Market Size Market Share by Type (2020-2025)
Figure 39. Europe Intravenous Immune Globulin Therapies Market Size Market Share by Application (2020-2025)
Figure 40. Germany Intravenous Immune Globulin Therapies Market Size Growth 2020-2025 ($ millions)
Figure 41. France Intravenous Immune Globulin Therapies Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Intravenous Immune Globulin Therapies Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Intravenous Immune Globulin Therapies Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Intravenous Immune Globulin Therapies Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Intravenous Immune Globulin Therapies Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Intravenous Immune Globulin Therapies Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Intravenous Immune Globulin Therapies Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Intravenous Immune Globulin Therapies Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Intravenous Immune Globulin Therapies Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Intravenous Immune Globulin Therapies Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Intravenous Immune Globulin Therapies Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Intravenous Immune Globulin Therapies Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)
Figure 54. APAC Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)
Figure 55. Europe Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)
Figure 57. United States Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)
Figure 58. Canada Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)
Figure 59. Mexico Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)
Figure 60. Brazil Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)
Figure 61. China Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)
Figure 62. Japan Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)
Figure 63. Korea Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)
Figure 65. India Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)
Figure 66. Australia Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)
Figure 67. Germany Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)
Figure 68. France Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)
Figure 69. UK Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)
Figure 70. Italy Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)
Figure 71. Russia Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)
Figure 72. Egypt Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)
Figure 73. South Africa Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)
Figure 74. Israel Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)
Figure 75. Turkey Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)
Figure 76. Global Intravenous Immune Globulin Therapies Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Intravenous Immune Globulin Therapies Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Intravenous Immune Globulin Therapies Market Size 2026-2031 ($ millions)